About Raven:
We are Raven, RA Capital’s healthcare incubator. From discovery to delivery, whether we incubate, accelerate or rejuvenate, Raven’s goal is to turn scientific breakthroughs into transformative therapies and get them quickly, safely and efficiently to the patients that need them most. Raven’s experienced scientists, operators, and healthcare innovators have deep sector expertise across therapeutics, diagnostics, devices and services. They have brought hundreds of therapeutics into development, managed hospital systems, optimized clinical trials and navigated payor and regulatory systems to deliver patient impact - and they are ready to work with you.
About RA Capital:
Founded in 2004, RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare, life sciences, and planetary health companies. RA Capital creates and funds innovative companies, from private seed rounds to public follow-on financings, allowing management teams to drive value creation from inception through commercialization and beyond. RA Capital's knowledge engine is guided by our Tech Atlas internal research division, and Raven, RA Capital’s company building team, offers entrepreneurs and innovators a collaborative and comprehensive platform to explore the novel and the re-imagined. RA Capital has more than 150 employees and over $10 billion in assets under management.
Raven is seeking a highly strategic and execution-oriented Director or Senior Director of Corporate Development to play a key role across capital formation, business development, and indication strategy initiatives within our incubator portfolio. This individual will work closely with founders, scientific leadership, and the Raven investment team to drive company creation and enable critical growth milestones across a range of therapeutic areas and modalities.
This is a highly visible, cross-functional role ideal for someone who thrives in fast-paced environments, brings both analytical and storytelling strength, and wants to help shape the next generation of biotech companies from the ground up.
Key ResponsibilitiesFundraising & Capital Formation- Partner with Raven team members and portfolio leadership to support fundraising efforts, including early-stage venture rounds, structured financings, and strategic transactions.
- Identify, engage, and manage relationships with venture capital firms, corporate venture groups, and institutional investors.
- Lead development of investor materials (pitch decks, financing plans, data rooms, FAQs, etc.) and support due diligence efforts.
- Help shape and refine company-level investment narratives in alignment with platform and pipeline milestones.
- Support financial modeling efforts in collaboration with internal and external stakeholders.
- Support strategic partnering efforts across the portfolio, including out-licensing, in-licensing, and R&D collaborations.
- Prepare external-facing BD materials and participate in meetings with potential partners or pharma stakeholders as needed.
- Conduct competitive and commercial landscape analyses to inform BD strategy and support licensing decisions.
- Track and manage BD funnel and diligence workstreams in collaboration with portfolio company leadership.
- Collaborate with scientific founders and platform teams to develop early indication prioritization frameworks.
- Conduct market, regulatory, and payer analysis to inform therapeutic area selection, sequencing, and positioning.
- Shape early go-to-market plans in coordination with Raven investment partners, commercial advisors, and company leadership.
- Support long-range planning efforts, including exit scenario modeling, valuation planning, and investor messaging development.
- 10+ years of relevant experience in corporate development, strategy, venture capital, investment banking, or biotech business operations.
- Ph.D., M.D., or other advanced degree in a life sciences field preferred.
- Demonstrated track record supporting or leading venture financings and/or strategic transactions in the biotech sector.
- Strong grasp of the early-stage biotech ecosystem, including venture and pharma dynamics.
- Excellent communication and storytelling skills with ability to craft and deliver compelling investor and partner narratives.
- Highly collaborative, low-ego approach with ability to operate independently and execute under tight timelines.
- Deep scientific curiosity and ability to quickly understand complex technical concepts across modalities and disease areas.
Preferred Attributes
- Experience in a company creation environment (e.g., incubator, venture firm, or startup).
- Familiarity with early clinical development decision points and how they inform BD/financing milestones.
- Prior work across multiple therapeutic areas including immunology, oncology, neurology, or genetic medicines.
- Comfort engaging with C-level executives, board members, and external partners.
- Awesome But Not Required: Interest in and comfort with early stage scientific operations - contracting with and managing CROs and consultants, building and executing scientific plans, in collaboration with company leadership
The base salary range reflects our good faith estimate at the time of posting. Final compensation will depend on factors like experience, skills, and location. The role may also be eligible for an annual bonus and long-term incentives. Compensation and benefits may be updated in the future.
What We Do
We are Raven, RA Capital’s healthcare incubator. From discovery to delivery, whether we incubate, accelerate or rejuvenate, Raven’s goal is to turn scientific breakthroughs into transformative therapies and get them quickly, safely and efficiently to the patients that need them most. Raven’s experienced scientists, operators, and healthcare innovators have deep sector expertise across therapeutics, diagnostics, devices and services. They have brought hundreds of therapeutics into development, managed hospital systems, optimized clinical trials and navigated payor and regulatory systems to deliver patient impact - and they are ready to work with you. We know the barriers and bottlenecks that can slow healthcare innovation, and we’ve built Raven companies, platforms and capabilities to mitigate them and accelerate the path-to-patient. From designing AI/ML-guided discovery learning loops to optimizing clinical trials, setting up payroll, or recruiting scientists and executives to enhance a company’s capabilities, Raven helps builders build. And Raven is no fly-by-night operation. We are company building with RA Capital, with access to their proprietary TechAtlas research team to precision-map solutions to opportunities and access to their Investment Teams for market insight. Integration with RA Capital enables creative capital solutions to support innovators at every stage of development. Raven seeks to build companies that make life better, and that our healthier, more productive future demands. Let’s invent that future together.
.jpg)
